With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this comprehensive conference will completely focus on allogeneic cell therapies and how to overcome the key clinical and commercial challenges.
Join industry leaders to:
Explore automation as a means to reduce the cost of allogeneic cell therapies
Address the need for effective cold chain supply to ensure allogeneic cell therapies are delivered to patients without losing desired characteristics
Discover means to commercialize allogeneic cell therapies with effective scale up/scale out
Assess the capabilities of genetic engineering to create bespoke allogeneic cell therapies
Highlight the need for comparability and analytical tools to assist process development
"Very well organized meeting with top researchers in this field: great overview of a dynamic subject area"
"Intimate setting where scientists and clinicians can have focused discussions around cell biology and clinical translation"
Conference Only (Industry Pricing): USD 2899.0,
Conference Only + 1 Workshop (Industry Pricing): USD 3399.0,
Conference Only + 2 Workshop (Industry Pricing): USD 3799.0,
Workshop Only (Industry Pricing): USD 599.0,
Conference Only (Service Providers): USD 3399.0,
Conference Only + 1 Workshop (Service Providers): USD 3799.0,
Conference Only + 2 Workshop (Service Providers): USD 4199.0,
Workshop Only (Service Providers): USD 799.0
Speakers: Anne Altmeyer, Adicet Bio Inc., Stewart Abbot, Adicet Bio Inc., Alison Moore, Allogene Therapeutics, Greg Liposky, Commercial Manufacturing Athersys, David Sourdive, Technical Operations Cellectis, Andre Choulika, Cellectis, Stefan Scherer, Cellectis, Xiaokui Zhang, Celularity, Jean-Pierre Latere, Celyad, Robert Igarashi, CytoSen Therapeutics, Bob Valamehr, Fate Therapeutics, Harpreet Singh, Immatics, Yannick Bulliard, Immatics, Lawrence Lamb, Incysus, Ralph Bradenberger, Nkarta Therapeutic, Shaun Stapleton, ReNeuron, Sophie Amsellem- Bosq, Servier, Angela Scott, TCBiopharm, Michael Leek, TCBiopharm, Evren Alici, Vycellix